No space Left for Intravenous thrombolysis in acute stroke

Muir, K. (2016) No space Left for Intravenous thrombolysis in acute stroke. Internal and Emergency Medicine, 11, 619. (doi: 10.1007/s11739-016-1448-0)

117999.pdf - Published Version
Available under License Creative Commons Attribution.



Recent successful clinical trials of endovascular thrombectomy for large artery ischaemic stroke have established the value of this treatment modality as an adjunct to intravenous thrombolysis, not as an alternative: thrombectomy delivery was undertaken in the context of highly efficient networks for acute thrombolysis delivery and the great majority of patients received IV thrombolytic drug treatment. Even for the minority of acute stroke patients for whom thrombectomy is potentially relevant, access will be limited by geography and service infrastructure. Developments in intravenous thrombolysis in the near future will likely produce safer and more effective intravenous treatments. Intravenous thrombolysis will remain the first line of treatment for the great majority of acute stroke patients.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Muir, Professor Keith
Authors: Muir, K.
College/School:College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience
Journal Name:Internal and Emergency Medicine
ISSN (Online):1970-9366
Published Online:15 April 2016
Copyright Holders:Copyright © 2016 The Authors
First Published:First published in Internal and Emergency Medicine 11:619
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record